NewLink Genetics Competitors and Similar CompaniesClear all
CytomX Therapeutics's competitors and similar companies include Sirnaomics US and Immodulon Therapeutics.
 CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Sirnaomics US Sirnaomics is a biopharmaceutical company developing oncology therapeutics by using RNA interference (RNAi) technology. |  Immodulon Therapeutics Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer. | |
Founding Date | Founding Date 2008 | Founding Date 2007 | Founding Date N/A |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations South San Francisco, US HQ | Locations Germantown, US HQ Cambridge, US | Locations Hayes, GB HQ London, GB |
Employees | Employees 15815% increase | Employees 3211% decrease | Employees 10 |
Funding | |||
Total funding raised | Total funding raised $ 132.4m | Total funding raised $ 162m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Sirnaomics US
HQ
Germantown, US
Sirnaomics is a biopharmaceutical company developing oncology therapeutics by using RNA interference (RNAi) technology.
View companyImmodulon Therapeutics
HQ
Hayes, GB
Employees
10
Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer.
View company